ArticleFrontiers in oncology2022

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.

Tingting Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.